This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Otsuka Pharmaceutical Company, Limited. Active years: 2014.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2014
Title: Osamu Mukeda: Innovator in Medicinal Chemistry
Introduction
Osamu Mukeda is a prominent inventor based in Osaka, Japan. He has made significant contributions to the field of medicinal chemistry, particularly in the development of treatments for fatty liver disease. His innovative work has led to the creation of a unique patent that addresses a critical health issue.
Latest Patents
Mukeda holds a patent for "Carbostyril derivatives including cilostazol for treating fatty liver." This invention relates to a medicament designed to prevent and/or treat fatty liver, utilizing cilostazol or a pharmaceutically acceptable salt as the active ingredient. This advancement has the potential to improve the quality of life for individuals suffering from this condition.
Career Highlights
Osamu Mukeda is associated with Otsuka Pharmaceutical Company, Limited, where he has been instrumental in research and development efforts. His work at Otsuka has allowed him to collaborate with other talented professionals in the field, further enhancing the impact of his inventions.
Collaborations
Mukeda has worked alongside notable colleagues such as Atsushi Nakajima and Koji Fujita. Their combined expertise has contributed to the success of various projects within the pharmaceutical industry.
Conclusion
Osamu Mukeda's contributions to medicinal chemistry, particularly through his patent for treating fatty liver, highlight his role as an innovative inventor. His work continues to influence the field and offers hope for improved treatments in the future.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile